November 12, 2008 - Clinical data presented at the American Heart Association 2008 Scientific Sessions this week on the use of the CVRx Rheos implantable system designed to treat hypertension and heart failure, shows Rheos Therapy significantly improved heart structure and function in patients with high blood pressure.

November 12, 2008 - Wireless cardiac device remote monitoring company BIOTRONIK said data presented at the American Heart Association (AHA) 2008 Scientific Sessions shows remote monitoring of its implantable cardioverter defibrillators (ICD) is a safe and effective alternative to conventional in-office follow-up care, which helps reduce the burden on capacity-constrained cardiac centers.

November 11, 2008 - In a randomized, multicenter clinical trial, catheter ablation has been shown to significantly outperform anti-arrhythmic drug (AAD) therapy for the treatment of symptomatic paroxysmal atrial fibrillation.

November 11, 2008 - Royal Philips Electronics today unveiled a new PageWriter TC70 cardiograph technology to help improve detection and identification of problems in the heart, including specific coronary artery obstructions, damaged heart muscle and abnormal rhythms at the American Heart Association's Scientific Sessions 2008.

November 11, 2008 - New data presented today at the America Heart Association's 2008 scientific sessions by Medtronic shows survival among patients with implantable cardioverter-defibrillators (ICDs) treated only with anti-tachycardia pacing (ATP) was superior to patients who experienced at least one shock-treated episode, demonstrating the clinical benefit of ATP.

November 11, 2008 - Today at the annual scientific sessions of the American Heart Association in New Orleans the first U.S. clinical trial data on Medtronic's Melody transcatheter pulmonary valve were presented.

November 11, 2008 - Global Therapeutics today initiated of the world's first clinical trial of a drug-eluting stent that uses an antisense RNA therapeutics agent aimed at silencing one of the genes (c-myc) responsible for causing arteries to reclose after stenting (restenosis).

The company said it hopes the ground-breaking technology advances the science of treating coronary artery disease beyond what current technologies can achieve. Trial results are expected in 2009.

Invivoā€™s next-generation MRI patient vital signs monitor, the Precess Patient Management Configuration, is built off of Invivoā€™s flagship Precess 3160 platform and reportedly utilizes the industryā€™s first wireless ECG and wireless SpO2 patient vital signs.

November 10, 2008 - GE Healthcare launched three new cardiac ultrasound devices for the U.S. market to aid 4D heart imaging and quantitative analysis at the 2008 meeting of the American Heart Association.

November 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its Apex PTCA Dilatation Catheter, a high-performance pre-dilatation balloon catheter developed specifically to address physicians' needs in treating the most challenging atherosclerotic lesions.

The catheter is available for distribution in both Monorail and Over-The-Wire (OTW) catheter platforms.

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now